Page last updated: 2024-10-21

beta-resorcylic acid and Glomerulosclerosis, Focal Segmental

beta-resorcylic acid has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

beta-resorcylic acid: RN given refers to parent cpd; structure

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Widmeier, E1
Yu, S1
Nag, A1
Chung, YW1
Nakayama, M1
Fernández-Del-Río, L1
Hugo, H1
Schapiro, D1
Buerger, F1
Choi, WI1
Helmstädter, M1
Kim, JW1
Ryu, JH1
Lee, MG1
Clarke, CF1
Hildebrandt, F1
Gee, HY1

Other Studies

1 other study available for beta-resorcylic acid and Glomerulosclerosis, Focal Segmental

ArticleYear
ADCK4 Deficiency Destabilizes the Coenzyme Q Complex, Which Is Rescued by 2,4-Dihydroxybenzoic Acid Treatment.
    Journal of the American Society of Nephrology : JASN, 2020, Volume: 31, Issue:6

    Topics: Animals; Enzyme Stability; Glomerulosclerosis, Focal Segmental; HEK293 Cells; Humans; Hydroxybenzoat

2020